Skip to main content
Premium Trial:

Request an Annual Quote

Edgar Braendle

Former ARUP Laboratories President and CEO Edgar Braendle has accepted a new role as executive vice president, head of research and development, and chief medical officer of Boston Biomedical, a developer of next-generation cancer therapeutics. ARUP announced in August that Braendle, who had headed the lab company for one year, was leaving to pursue new opportunities. Prior to working at ARUP, Braendle had worked at Novartis Medicines, where he led the company's precision medicine approach, delivering complementary and companion diagnostics. At Boston Biomedical, he will report to CEO Patricia Andrews.